A concise enantioselective entry to the synthesis of deoxy-azasugars

Organic Letters

Volumn 2, Issue 1, 2000, Pages 93-95

  Martín, Rubén ^a   Moyano, Albert ^a   Pericàs, Miquel A ^a   Riera, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN; 5 AMINO 5 DEOXYGALACTOPYRANOSE; 5-AMINO-5-DEOXYGALACTOPYRANOSE; DEOXYSUGAR; DRUG DERIVATIVE; ENZYME INHIBITOR; GALACTOSAMINE; GLYCOSIDASE; HETEROCYCLIC COMPOUND; PIPERIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; DRUG ANTAGONISM; STEREOISOMERISM; SYNTHESIS;

1-DEOXYNOJIRIMYCIN; AZA COMPOUNDS; DEOXY SUGARS; ENZYME INHIBITORS; GALACTOSAMINE; GLYCOSIDE HYDROLASES; MOLECULAR STRUCTURE; PIPERIDINES; STEREOISOMERISM;

EID: 0033643441     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol991280u     Document Type: Article

References (45)

1. (a) Ganem, B. Acc. Chem. Res. 1996, 29, 340-347.
2. (b) Sinnott, M. L. Chem. Rev. 1990, 90, 1171-1202.
3. (a) Look, G. C.; Fotsch, C. H.; Wong, C. H. Acc. Chem. Res. 1993, 26, 182-190.
4. (b) van den Broek, L. A. G. M.; Vermaas, D. J.; Heskamp, B. M.; van Boeckel, C. A. A.; Tan, M. C. A. A.; Bolscher, J. G. M.; Ploegh, H. L.; van Kemenade, F. J.; de Goede, R. E. Y.; Miedema, F. Recl. Trav. Chim. Pays-Bas 1993, 112, 82-94.
5. (c) Junge, B.; Matzke, M.; Stoltefuss, J. Handb. Exp. Pharmacol. 1996, 119, 411 -482.
6. (d) Bols, M. Acc. Chem. Res. 1998, 31, 1-8.
7. (e) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. 1999, 38, 750-770.
8. Johnston, P. S.; Lebovitz, H. E.; Coniff, R. F.; Simonson, D. C.; Raskin, P.; Munera, C. L. J. Clin. Endocrinol Metab 1998, 83, 1515-1522.
9. Gruters, R. A.; Neefjes, J. J.; Tersmette, M.; de Goede, R. E. Y.; Tulp, A.; Huisman, H. G.; Miedema, F.; Ploegh, H. L. Nature 1987, 330, 74-77.
10. Tsuruoka, T.; Fukuyasu, H.; Ishii, M.; Usui, T.; Shibahara, S.; Inouye, S. J. Antibiot. 1996, 49, 155-161.
11. Hughes, A. B.; Rudge, A. J. Nat. Prod. Rep. 1994, 11, 135-162.
12. (a) Fellows, L. E.; Bell, E. A.; Lynn, D. G.; Pilkiewicz, F.; Miura, I.; Nakanishi, K. J. Chem. Soc., Chem. Commun. 1979, 977-978.
13. (b) Fuhrmann, U.; Bause, E.; Legler, G.; Ploegh, H. Nature 1984, 307, 755-758.
14. Miyake, Y.; Ebata, M. J. Antibiot. 1987, 40, 122-123.
15. Selected synthesis of 1-deoxymannojirimycin: (a) Meyers, A. I.; Andres, C. J.; Resek, J. E.; Woodall, C. C.; McLaughlin, M. A.; Lee, P. H.; Price, D. A. Tetrahedron 1999, 55, 8931-8952.
16. (b) Wu, X.-D.; Khim, S.-K.; Zhang, X.; Cederstrom, E. M.; Mariano, P. S. J. Org. Chem. 1998, 63, 841-859.
17. (c) Xu, Y.-M.; Zhou, W.-S. J. Chem. Soc., Perkin Trans. 1 1997, 741-746.
18. (d) Baxter, E. W.; Reitz, A. B. J. Org. Chem. 1994, 59, 3175-3185.
19. (e) Park, K. H.; Yoon, Y. J.; Lee, S. G. J. Chem. Soc., Perkin Trans. 1 1994, 2621-2623.
20. (f) Fleet, G. W. J.; Ramsden, N. G.; Witty, D. R. Tetrahedron 1989, 45, 327-336.
21. (g) Fleet, G. W. J.; Ramsden, N. G.; Witty, D. R. Tetrahedron 1989, 45, 319-326.
22. (h) Pederson, R. L.; Kim, M.-J.; Wong, C.-H. Tetrahedron Lett. 1988, 29, 4645-4648.
23. (i) Bernotas, R. C.; Ganem, B. Tetrahedron Lett. 1985, 26, 1123-1126.
24. Asano, K.; Hakogi, T.; Iwama, S.; Katsumura, S. Chem. Commun. 1999, 41-42.
25. Ciufolini, M. A.; Hermann, C. Y. W.; Dong, Q.; Shimizu, T.; Swaminathan, S.; Xi, N. Synlett 1998, 105-114.
26. Shirai, M.; Okamoto, S,; Sato, F. Tetrahedron Lett. 1999, 40, 5331-5332.
27. (a) Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765-5780.
28. (b) Katsuki, T.; Martin, V. S. Org. React. 1996, 48, 1-299.
29. (a) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413-4450.
30. (b) Grubbs, R. H.; Miller, S. J.; Fu, G. C. Acc. Chem. Res. 1995, 28, 446-552.
31. (c) Schuster, M.; Blechert, S. Angew. Chem., Int. Ed. Engl. 1997, 36, 2036-2056.
32. (d) Armstrong, S. K. J. Chem. Soc., Perkin Trans. 1 1998, 371-388.
33. (e) Ivin, K. J. J. Mol. Catal. A: Chem. 1998, 133, 1-16.
34. Other approaches to azasugars by ring-closing methatesis: (a) Pandit, U. K.; Overkleeft, H. S.; Borer, B. C.; Bieräugel, H. Eur. J. Org. Chem. 1999, 959-968.
35. (b) White, J. D.; Hrnciar, P.; Yokochi, A. F. T. J. Am. Chem. Soc. 1998, 720, 7359-7360.
36. (c) Huwe, C. M.; Blechert, S. Synthesis 1997, 61-67.
37. (a) Roush, W. R.; Adam, M. A. J. Org. Chem. 1985, 50, 3752-3757.
38. (b) Clayden, J.; Collington, E. W.; Lamont, R. B.; Warren, S. Tetrahedron Lett. 1993, 34, 2203-2206.
39. (c) Nagamitsu, T.; Sunazuka, T.; Tanaka, H.; Omura, S.; Sprengeler, P. A.; Smith, A. B., III. J. Am. Chem. Soc. 1996, 118, 3584-3590.
40. Baldwin, J. E.; Li, C.-S. J. Chem. Soc., Chem. Commun. 1988, 261-263.
41. 13C NMR, and MS data.
42. Schneider, M. P.; Goldbach, M. J. Am. Chem. Soc. 1980, 102, 6114-6116.
43. Pure (2S,3S)-2,3-epoxy-4-penten-1-ol (>91% ee) can be obtained by distilation of the crude reaction mixture. See: Wershofen, S.; Scharf, H.-D. Synthesis 1988, 854-858.
44. Cyclic carbonate 11 can be seen as arising from an acyl migration product of 5. Treatment of 5 with TMS-Cl/imidazole/DMF afforded a complex mixture of products wherein 11 was present.
45. Since 4 and 5 are highly crystalline solids, it should be possible to increase the enantiomeric purity of 4 by crystallization.